| Determining cell type abundance and expression from bulk tissues with digital cytometry AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ... Nature biotechnology 37 (7), 773-782, 2019 | 2729 | 2019 |
| Profiling cell type abundance and expression in bulk tissues with CIBERSORTx CB Steen, CL Liu, AA Alizadeh, AM Newman Stem Cell Transcriptional Networks: Methods and Protocols, 135-157, 2020 | 313 | 2020 |
| Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition BY Nabet, MS Esfahani, EJ Moding, EG Hamilton, JJ Chabon, H Rizvi, ... Cell 183 (2), 363-376. e13, 2020 | 259 | 2020 |
| Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma U Randen, G Trøen, A Tierens, C Steen, A Warsame, K Beiske, ... Haematologica 99 (3), 497, 2014 | 175 | 2014 |
| T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma AX Lozano, AA Chaudhuri, A Nene, A Bacchiocchi, N Earland, MD Vesely, ... Nature medicine 28 (2), 353-362, 2022 | 163 | 2022 |
| Atlas of clinically distinct cell states and ecosystems across human solid tumors BA Luca*, CB Steen* (co-first), M Matusiak, A Azizi, S Varma, C Zhu, ... Cell, 2021 | 146 | 2021 |
| The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma CB Steen*, BA Luca* (co-first), MS Esfahani, A Azizi, BJ Sworder, ... Cancer Cell, 2021 | 135 | 2021 |
| T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling SE Josefsson, K Huse, A Kolstad, K Beiske, D Pende, CB Steen, ... Clinical Cancer Research 24 (4), 870-881, 2018 | 92 | 2018 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 91 | 2022 |
| Artesunate shows potent anti-tumor activity in B-cell lymphoma TK Våtsveen, MR Myhre, CB Steen, S Wälchli, OC Lingjærde, B Bai, ... Journal of hematology & oncology 11, 1-12, 2018 | 79 | 2018 |
| ALIX and ESCRT-III Coordinately Control Cytokinetic Abscission during Germline Stem Cell Division In Vivo ÅH Eikenes, L Malerød, AL Christensen, CB Steen, J Mathieu, IP Nezis, ... PLoS genetics 11 (1), e1004904, 2015 | 65 | 2015 |
| Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: results from two nordic lymphoma group trials with more than 10 years of … S Lockmer, B Østenstad, H Hagberg, H Holte, AS Johansson, BE Wahlin, ... J Clin Oncol 36 (33), 3315-3323, 2018 | 60 | 2018 |
| High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE MR Vahid*, EL Brown*, CB Steen* (co-first), W Zhang, HS Jeon, M Kang, ... Nature Biotechnology, 1-6, 2023 | 50 | 2023 |
| Computational approaches for characterizing the tumor immune microenvironment CC Liu, CB Steen, AM Newman Immunology 158 (2), 70-84, 2019 | 36 | 2019 |
| Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia MD Knudsen, T de Lange, E Botteri, DH Nguyen, H Evensen, CB Steen, ... World journal of gastroenterology 22 (27), 6276, 2016 | 33 | 2016 |
| Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series JF Wise, S Nakken, CB Steen, D Vodák, G Trøen, B Johannessen, ... Blood advances 4 (9), 1859-1866, 2020 | 10 | 2020 |
| A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy CB Steen, E Leich, JH Myklebust, S Lockmer, JF Wise, BE Wahlin, ... haematologica 104 (10), e460, 2019 | 10 | 2019 |
| Towards non-invasive classification of DLBCL genetic subtypes by Ctdna profiling MS Esfahani, S Alig, DM Kurtz, J Soo, MC Jin, C Macaulay, AFM Craig, ... Blood 134, 551, 2019 | 9 | 2019 |
| Robust alignment of single-cell and spatial transcriptomes with CytoSPACE MR Vahid*, EL Brown*, CB Steen* (co-first), M Kang, AJ Gentles, ... bioRxiv, 2022 | 4 | 2022 |
| Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis SS Sikandar, GS Gulati, J Antony, I Fetter, AH Kuo, WHD Ho, ... Science Advances 8 (45), eabm3548, 2022 | 2 | 2022 |
Knut LiestølUniversity of Oslo在 ifi.uio.no 的电子邮件经过验证
